Verzenios 50 mg film-coated tablets
GEICAM/2019-01
Phase 2 small_molecule active
Quick answer
Verzenios 50 mg film-coated tablets for High/intermediate risk hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative breast cancer patients with indication of neoadjuvant therapy. is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- High/intermediate risk hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative breast cancer patients with indication of neoadjuvant therapy.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active